New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases

被引：42
|
作者：
Mastalerz, Harold
Chang, Ming
Chen, Ping
Dextraze, Pierre
Fink, Brian E.
Gavai, Ashvinikumar
Goyal, Bindu
Han, Wen-Ching
Johnson, Walter
Langley, David
Lee, Francis Y.
Marathe, Punit
Mathur, Arvind
Oppenheimer, Simone
Ruediger, Edward
Tarrant, James
Tokarski, John S.
Vite, Gregory D.
Vyas, Dolatrai M.
Wong, Henry
Wong, Tai W.
Zhang, Hongjian
Zhang, Guifen
机构：
[1] Dept Oncol Chem, Wallingford, CT 06492 USA
[2] Dept Discovery Biol, Wallingford, CT 06492 USA
[3] Dept Pharmaceut Candidate Optimizat, Wallingford, CT 06492 USA
[4] Dept Comp Aided Drug Design, Wallingford, CT 06492 USA
[5] Dept Chem Synth, Wallingford, CT 06492 USA
[6] Bristol Myers Squibb Pharmaceut Inst, Princeton, NJ 08543 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 07期
关键词：
EGFR; HER2; receptor tyrosine kinase inhibitor; pyrrolotriazine;
D O I：
10.1016/j.bmcl.2007.01.002
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Novel C-5 substituted pyrrolotriazines were optimized for dual EGFR and HER2 protein tyrosine kinase inhibition. The lead compound exhibited promising oral efficacy in both EGFR and HER2 driven human tumor xenograft models. It is hypothesized that its C-5 morpholine side chain binds in the ribose phosphate portion of the ATP binding pocket. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2036 / 2042
页数：7
相关论文
共 50 条
  • [1] Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases
    Mastalerz, Harold
    Chang, Ming
    Gavai, Ashvinikumar
    Johnson, Walter
    Langley, David
    Lee, Francis Y.
    Marathe, Punit
    Mathur, Arvind
    Oppenheimer, Simone
    Tarrant, James
    Tokarski, John S.
    Vite, Gregory D.
    Vyas, Dolatrai M.
    Wong, Henry
    Wong, Tai W.
    Zhang, Hongjian
    Zhang, Guifen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2828 - 2833
  • [2] Pyrrolotriazine dual EGFR/HER2 protein tyrosine kinase inhibitors with solubilizing groups at C-5
    Mastalerz, Harold
    Chang, Ming
    Chen, Ping
    Cook, Donald
    Dextraze, Pierre
    Fink, Brian E.
    Gavai, Ashvinikumar
    Goyal, Bindu
    Han, Wen-Ching
    Johnson, Walter
    Kim, Soong-Hoon
    Langley, David
    Lee, Francis
    Leavitt, Kenneth
    Norris, Derek
    Marathe, Punit
    Mathur, Arvind
    Oppenheimer, Simone
    Ruediger, Edward
    Tarrant, James
    Tokarski, John
    Vite, Gregory
    Vyas, Dolatrai
    Wong, Henry
    Wong, Tai
    Zhang, Hongjian
    Zhang, Guifen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 806 - 806
  • [3] MEDI 446-Pyrrolotriazine dual EGFR/HER2 protein tyrosine kinase inhibitors with solubilizing groups at C-5
    Kastrati, Irida
    Qin, Zhihui
    Petukhov, Pavel A.
    Bolton, Judy L.
    Thatcher, Gregory R. J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 922 - 922
  • [4] New dual inhibitors of EGFR and HER2 protein tyrosine kinases
    Fink, BE
    Vite, GD
    Mastalerz, H
    Kadow, JF
    Kim, SH
    Leavitt, KJ
    Du, K
    Crews, D
    Wong, TW
    Hunt, JT
    Vyas, DM
    Tokarski, JS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4774 - 4779
  • [5] 5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases
    Mastalerz, Harold
    Chang, Ming
    Chen, Ping
    Fink, Brian E.
    Gavai, Ashvinikumar
    Han, Wen-Ching
    Johnson, Walter
    Langley, David
    Lee, Francis Y.
    Leavitt, Kenneth
    Marathe, Punit
    Norris, Derek
    Oppenheimer, Simone
    Sleczka, Bogdan
    Tarrant, James
    Tokarski, John S.
    Vite, Gregory D.
    Vyas, Dolatrai M.
    Wong, Henry
    Wong, Tai W.
    Zhang, Hongjian
    Zhang, Guifen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4947 - 4954
  • [6] New dual inhibitors of HER1 and HER2 protein tyrosine kinases.
    Vite, GD
    Mastalerz, H
    Fink, BE
    Gavai, AV
    Hunt, JT
    Tokarski, JS
    Vyas, DM
    Wong, TW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U3 - U3
  • [7] Pyrrolotriazine-5-carboxylate ester inhibitors of EGFR and HER2 protein tyrosine kinases and a novel one-pot synthesis of C-4 subsitituted pyrrole-2,3-dicarboxylate diesters
    Mastalerz, Harold
    Gavai, Ashvinikumar V.
    Fink, Brian
    Struzynski, Charles
    Tarrant, James
    Vite, Gregory D.
    Wong, Tai W.
    Zhang, Guifen
    Vyas, Dolatrai M.
    CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 2006, 84 (04): : 528 - 533
  • [8] Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
    Lu Yang
    Arup Bhattacharya
    Yun Li
    Sandra Sexton
    Xiang Ling
    Fengzhi Li
    Yuesheng Zhang
    Journal of Experimental & Clinical Cancer Research, 41
  • [9] Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
    Yang, Lu
    Bhattacharya, Arup
    Li, Yun
    Sexton, Sandra
    Ling, Xiang
    Li, Fengzhi
    Zhang, Yuesheng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [10] A novel dual inhibitor of HER1 and HER2 protein tyrosine kinases
    Mastalerz, H
    Dextraze, P
    Gavai, A
    Johnson, W
    Lee, F
    Oppenheimer, S
    Ruediger, E
    Tarrant, J
    Vite, G
    Vyas, D
    Wong, TW
    Zhang, GF
    Zhang, HJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2717 - U2717
12345